We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The chapter outlines diagnostic practices with DSM-5 and ICD-11, practical steps of conducting a diagnostic interview, and to conduct a Mental State Examination.
Valid diagnostic standards are important for both the treatment and scientific study of SUD. Primary features of SUD are uncontrolled compulsive drug use, and harmful consequences of drug use. The DSM-5, a successor to the DSM-IV, lists diagnostic criteria for SUD, and its use is the standard for diagnosis of the disorder. Physiological withdrawal symptoms are only 1 of 11 possible criteria, so are neither necessary nor sufficient for a positive diagnosis. Differences among individuals in gender, psychiatric disorders, and other factors can influence the diagnosis of SUD. Less severe cases may be difficult to distinguish from heavy but non-pathological use of drugs, including alcohol. Screening tests cannot provide a diagnosis, but can identify individuals whose drug use warrants a full diagnostic interview. For those with an SUD, the diagnostic interview can be the initial phase of treatment by establishing a therapeutic relationship with a mental health professional. A skilled clinician can often counteract the denial and defensiveness that can prevent an accurate diagnosis of SUD.
To examine the risk of depression and anxiety in MS patients in the post-diagnostic period by using clinical screening instruments and a diagnostic structured clinical interview.
Method
A population of 134 MS patients was examined for the risk of depression and anxiety in the post-diagnostic period of MS using the clinical screening instruments Beck Depression Inventory (BDI) and Hospital Anxiety and Depression Scale (HADS). Within six weeks of diagnosis, patients with cut-off > 12 for BDI and > 7 for HADS were offered a clinical structured interview using the Schedules for Clinical Assessment in Neuropsychiatry/SCAN Version 2.1.
Results
The prevalence of depressive symptoms and depression in the post-diagnostic period of MS was 49.2% when using the screening instruments, but only 15.2% when using the SCAN interview. For anxiety, the prevalence was 3.4% for both the screening instruments and the SCAN interview in the post-diagnostic period of MS.
Conclusion
MS patients have a risk of depression and anxiety in the post-diagnostic period of MS, but it is crucial to consider which tools to use in a clinical setting to investigate depression and anxiety in MS patients.
Disclosure of interest
The authors have not supplied their declaration of competing interest.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.